Cullinan Therapeutics, Inc. CGEM Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s current ratio?
- Cullinan Therapeutics, Inc. (CGEM) reported current ratio of 10.3× in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s current ratio changed year-over-year?
- Cullinan Therapeutics, Inc.'s current ratio decreased by 11.5% year-over-year, from 11.6× to 10.3×.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s current ratio has grown at a -7.1% compound annual growth rate (CAGR), from 14.8× to 10.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.